Moderate To Severe Vernal Keratoconjunctivitis clinical trials

Explore recruiting moderate to severe vernal keratoconjunctivitis clinical trials.

Recruiting moderate to severe vernal keratoconjunctivitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate To Severe Vernal Keratoconjunctivitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety assessment of T1695 ophthalmic suspension, versus Ciclosporin ophthalmic emulsion, in participants with moderate to severe Vernal Keratoconjunctivitis (VKC)

Spain, Italy, Bulgaria, France, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Moderate To Severe Vernal Keratoconjunctivitis trials by city

Moderate To Severe Vernal Keratoconjunctivitis in Toronto Moderate To Severe Vernal Keratoconjunctivitis in Vancouver Moderate To Severe Vernal Keratoconjunctivitis in Montreal Moderate To Severe Vernal Keratoconjunctivitis in Calgary Moderate To Severe Vernal Keratoconjunctivitis in Edmonton Moderate To Severe Vernal Keratoconjunctivitis in Ottawa Moderate To Severe Vernal Keratoconjunctivitis in Winnipeg Moderate To Severe Vernal Keratoconjunctivitis in Quebec City Moderate To Severe Vernal Keratoconjunctivitis in Hamilton Moderate To Severe Vernal Keratoconjunctivitis in Kitchener Moderate To Severe Vernal Keratoconjunctivitis in London Moderate To Severe Vernal Keratoconjunctivitis in Halifax Moderate To Severe Vernal Keratoconjunctivitis in New York Moderate To Severe Vernal Keratoconjunctivitis in Los Angeles Moderate To Severe Vernal Keratoconjunctivitis in Chicago Moderate To Severe Vernal Keratoconjunctivitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease